Description

Gresham House Strategic plc operates as an investment fund, specializing in various capital injections including private investments in public equity (PIPEs), pre-initial public offering (pre-IPO) financing, growth and acquisition funding, and recovery capital. The fund directs its investments towards companies primarily within the financial services, media, information and communication technology, digital information and technology, healthcare, and life sciences industries. While its main geographic focus is on the United Kingdom and Europe, it also undertakes co-investments beyond Europe in collaboration with local venture capital firms. This fund actively seeks opportunities for follow-on investments, typically acquiring ownership stakes of between 5% and 25% in target companies, which can be paid for with cash or shares. The intended investment horizon for these holdings ranges from three to five years. It invests in both smaller public companies and private enterprises. For public company investments, the fund targets those listed on the FTSE All-Share and AIM All-Share indices that meet specific criteria: stocks trading more than 50% below their three-year price peak, an Enterprise Value to EBITDA multiple less than 7 times, gearing above 75%, a Return on Capital Employed (ROCE) exceeding 10%, and a Free Cash Flow (FCF) Yield greater than 10%. In the private sector, investments encompass peer-to-peer (P2P) opportunities, various forms of equity and equity-related instruments, preferred equity, and preferred quasi-equity positions, including both convertible and non-convertible debt, as well as mezzanine financing. Excluding cash, the fund's portfolio is characterized by a weighted average Enterprise Value to EBITDA ratio surpassing 5 times and, as per broker forecasts, achieved over 10% growth in 2017. Ultimately, Gresham House Strategic plc aims for a long-term net Internal Rate of Return (IRR) of 15%.